Mehdi Yazdi the Art of API Method Development
Posted: October 12, 2018
Dr. Mehdi Yazdi Director of Analytical Services talks about the art of API method development at PCI Synthesis.
Related posts:
Manufacturing Generic Versions of Controlled Substances
Why Sharpen Your Focus on API Analytic Methods?
The Hunt for Qualified Biotech Talent Continues
API Manufacturing: What Are 5 Best Practices in Qualifying Suppliers?
Easing Process Validation Rules for Small-Volume Manufacturers Might Be First Step in Easing Drug S...
About the Author
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...